Skip to content
My WebMD Sign In, Sign Up

Melanoma/Skin Cancer Health Center

Font Size

Melanoma: Cell Ringleaders Found

Cells That Spur Melanoma Growth May Make Good Treatment Targets, Study Shows
WebMD Health News
Reviewed by Louise Chang, MD

Jan. 16, 2008 -- Melanoma, the deadliest skin cancer, may get nipped in the bud by targeting certain cells.

Those findings could lead to new melanoma treatments, say researchers, including Tobias Schatton, PharmD, of the Transplantation Research Center of Children's Hospital Boston and Brigham & Women's Hospital in Boston.

The researchers found certain cells that spur aggressive melanoma growth and resist chemotherapy. Targeting those cells with antibodies curbed melanoma in lab tests on mice.

The antibody treatment isn't ready for use in people yet. But the lab tests are "a significant step" toward new melanoma therapies, Schatton's team writes in tomorrow's edition of Nature.

The researchers also call for more studies to see if the same cells, or cells like them, launch other types of cancer.

Meanwhile, early detection matters. The National Cancer Institute lists these possible signs of melanoma:

  • A mole that changes in size, shape, or color
  • A mole that has irregular edges or borders
  • A multicolored mole
  • An asymmetrical mole (if the mole is divided in half, the two halves are different in size or shape)
  • An itchy mole
  • A mole that oozes, bleeds, or is ulcerated (has a hole that shows underlying tissue)
  • Change in pigmented (colored) skin
  • Satellite moles (new moles that grow near an existing mole)


Today on WebMD

Woman checking out tan lines
Cancer Fighting Foods Slideshow
what is your cancer risk
Could Caffeine Help Fight Skin Cancer

12 Ways to Protect Your Skin from Melanoma
precancerous lesions slideshow
Do You Know Your Melanoma ABCs
15 Cancer Symptoms Men Ignore

screening tests for men
Vitamin D
Is That Mole Skin Cancer
Brilliant sun rays

WebMD Special Sections